Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Association of plasma uracil concentration with 5-FU pharmacokinetics, dose-limiting toxicity, and DPYD genotype in patients with gastrointestinal cancer
Ness, Dylan B., Hourdequin, Kathryn Cunningham, Ripple, Gregory H., Amin, Manik A., Lord-Halvorson, Sierra, Khan, Wahab A., Deharvengt, Sophie J., Dragnev, Konstantin H., Tsongalis, Gregory J., Zhao, Wenyan, Tosteson, Tor D., Lewis, Lionel D
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Loading…
The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma
Runge, John S, Brown, Anna B, Phillips, Tycel J, Kaminski, Mark S, Carty, Shannon A, Wilcox, Ryan A
Published in Journal of oncology pharmacy practice (01.04.2023)
Published in Journal of oncology pharmacy practice (01.04.2023)
Get more information
Journal Article
Loading…
A pharmaceutical industry survey results on the cycle time, drivers and enablers, for key deliverables in the early phase of drug product development from dose limiting toxicity to first subject first dose: The survey conducted by the IQ cycle time benchmarking working group
Campbell, Gossett A., Barrett, Stephanie E., Thakral, Seema, Lowinger, Michael, Faassen, Fried, Vander Kamp, Kirk A., Wagner, Daniel, Bargmann-Leyder, Nathalie, Badawy, Sherif, Gaebele, Tracy, Snyder, Phillip
Published in Journal of drug delivery science and technology (01.06.2025)
Published in Journal of drug delivery science and technology (01.06.2025)
Get full text
Journal Article
Loading…
A Phase I/II trial design when response is unobserved in subjects with dose-limiting toxicity
Braun, Thomas M, Kang, Shan, Taylor, Jeremy Mg
Published in Statistical methods in medical research (01.04.2016)
Published in Statistical methods in medical research (01.04.2016)
Get more information
Journal Article
Loading…
NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial
Majerus, Elaine M., Ataga, Kenneth I., Vichinsky, Elliott, Eaton, Cheryl A., Mazanet, Rosemary, Nathan, David G., Field, Joshua J.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Loading…
Pharmacokinetics and Safety of PTC596, a Novel Tubulin‐Binding Agent, in Subjects With Advanced Solid Tumors
Shapiro, Geoffrey I., O'Mara, Edward, Laskin, Oscar L., Gao, Lan, Baird, John D., Spiegel, Robert J., Kaushik, Diksha, Weetall, Marla, Colacino, Joseph, O'Keefe, Kylie, Branstrom, Arthur, Goodwin, Elizabeth, Infante, Jeffrey, Bedard, Philippe L., Kong, Ronald
Published in Clinical pharmacology in drug development (01.08.2021)
Published in Clinical pharmacology in drug development (01.08.2021)
Get full text
Journal Article
Loading…
Abstract B56: A phase 1, open-label, dose escalation, nonrandomized study to assess the maximum tolerated dose, dose limiting toxicity, and pharmacokinetics of OPB-31121 in subjects with advanced solid tumors
Kurzrock, Razelle, Naing, Aung, Falchook, Gerald S., Hong, David S., Elekes, Agnes, Sumida, Takumi, Bricmont, Patricia, Kodama, Takeshi, Motoyama, Masaaki, Patil, Shiva, Lee, Jennifer, Jones, Suzanne, Infante, Jeffrey, Burris, Howard, Bendell, Johanna
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Loading…
Loading…
A comparative study of dose-finding models with late-onset toxicities
Park, Jihyun, Park, Mira, Lee, Jae Won
Published in Communications in statistics. Simulation and computation (09.06.2025)
Published in Communications in statistics. Simulation and computation (09.06.2025)
Get full text
Journal Article
Loading…
Safety, Tolerability, and Pharmacokinetics of NorUrsodeoxycholic Acid (Shilpa Medicare Limited, India) in Healthy Adults: Results From a Phase I Open‐Label Dose‐Escalation Study
Panuganti, Veerendra Kumar, Alluri, Chandrasekhar Varma, Dundigalla, Mamatha Reddy, Mohammad, Javeed, Madala, Pavan Kumar, K. S. S. V. V., Sanyasirao
Published in Advances in pharmacological and pharmaceutical sciences (01.01.2025)
Published in Advances in pharmacological and pharmaceutical sciences (01.01.2025)
Get full text
Journal Article
Loading…
Dose-limiting toxicity of rifabutin in AIDS-related complex: syndrome of arthralgia/arthritis
Siegal, F P, Eilbott, D, Burger, H, Gehan, K, Davidson, B, Kaell, A T, Weiser, B
Published in AIDS (London) (01.05.1990)
Published in AIDS (London) (01.05.1990)
Get more information
Journal Article
Loading…
Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors
Wang, Xian-Huo, Zhou, Shi-Yong, Qian, Zheng-Zi, Zhang, Hui-Lai, Qiu, Li-Hua, Song, Zheng, Zhao, Jing, Wang, Ping, Hao, Xi-Shan, Wang, Hua-Qing
Published in Expert opinion on drug metabolism & toxicology (01.02.2013)
Published in Expert opinion on drug metabolism & toxicology (01.02.2013)
Get more information
Journal Article
Loading…
Moleculin Receives Approval to Extend Dose Escalation in Phase 1/2 European Clinical Trial Evaluating Annamycin for the Treatment of Acute Myeloid Leukemia: Protocol amendment allows for change in dose limiting toxicity (DLT) criteria for future enrolled subjects
Published in PR Newswire
(13.07.2021)
Get full text
Newsletter
Loading…
Loading…
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors
Dunbar, E. M., Coats, B. S., Shroads, A. L., Langaee, T., Lew, A., Forder, J. R., Shuster, J. J., Wagner, D. A., Stacpoole, P. W.
Published in Investigational new drugs (01.06.2014)
Published in Investigational new drugs (01.06.2014)
Get full text
Journal Article
Loading…
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK
Humphries, Christopher, Addison, Melisande, Aithal, Guruprasad, Boyd, Julia, Briody, Lesley, Campbell, John D M, Candela, Maria Elena, Clarke, Ellise, Coulson, James, Downing-James, Nicholas, Fontana, Robert John, Geddes, Ailsa, Grahamslaw, Julia, Grant, Alison, Heye, Anna, Hutchinson, James A, Jones, Ashley, Mitchell, Fiona, Moore, Joanna, Riddell, Alice, Rodriguez, Aryelly, Thomas, Angela, Tucker, Garry, Walker, Kim, Weir, Christopher J, Woods, Rachel, Zahra, Sharon, Forbes, Stuart J, Dear, James W
Published in BMJ open (09.12.2024)
Published in BMJ open (09.12.2024)
Get full text
Journal Article
Loading…
A phase 1 study investigating DX-2930 in healthy subjects
Chyung, Yung, Vince, Bradley, Iarrobino, Ryan, Sexton, Dan, Kenniston, Jon, Faucette, Ryan, TenHoor, Chris, Stolz, Leslie E., Stevens, Chris, Biedenkapp, Joseph, Adelman, Burt
Published in Annals of allergy, asthma, & immunology (01.10.2014)
Published in Annals of allergy, asthma, & immunology (01.10.2014)
Get full text
Journal Article
Loading…
Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS – A Novel Therapeutic Opportunity
Winstedt, Lena, Järnum, Sofia, Nordahl, Emma Andersson, Olsson, Andreas, Runström, Anna, Bockermann, Robert, Karlsson, Christofer, Malmström, Johan, Palmgren, Gabriella Samuelsson, Malmqvist, Ulf, Björck, Lars, Kjellman, Christian
Published in PloS one (2015)
Published in PloS one (2015)
Get full text
Journal Article
Loading…
A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors
Keam, Bhumsuk, Ock, Chan-Young, Kim, Tae Min, Oh, Do-Youn, Kang, Won Ki, Park, Yeon Hee, Lee, Jeeyun, Lee, Ji Hye, Ahn, Yoen Hee, Kim, Hyeon Ju, Chang, Sook Kyung, Park, Jihyun, Choi, Ji Yea, Song, Yun Jeong, Park, Young Suk
Published in Investigational new drugs (01.12.2021)
Published in Investigational new drugs (01.12.2021)
Get full text
Journal Article
Loading…
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
Krishnan, Mridula, Bociek, R. Gregory, Fanale, Michelle, Iyer, Swaminathan P., Lechowicz, Mary Jo, Bierman, Philip J., Armitage, James O., Lunning, Matthew, Kallam, Avyakta, Vose, Julie M.
Published in Annals of hematology (01.02.2022)
Published in Annals of hematology (01.02.2022)
Get full text
Journal Article